We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Micro-Embolic Events and Their Clearing in the Brain. A Narrative Review.
Summary
This narrative review discussed micro-embolic events in the brain's circulation, including those caused by microplastics, and the mechanisms by which they are cleared. It highlighted that microplastics can act as microvascular emboli, potentially impairing cerebral blood flow and contributing to neurological injury.
BACKGROUND: The cerebral circulation is continuously challenged by intravascular micrometer-sized particles that become trapped microvascular-emboli. These particles may include micro-thrombi, stiffened erythrocytes, and leukocytes, while also fat particles, air, and microplastics may cause microvascular embolism. REVIEW SCOPE: In this narrative review, we discuss these embolization processes and their acute and chronic consequences. These relate to the local flow interruption as well as the direct interaction with the endothelium. In addition, we address the clearing processes, including local thrombolysis and extravasation, or angiophagy, of the emboli. CONCLUSION: A continuous balance exists between embolic events and their resolution under normal conditions. Increased micro-embolic rates, as occur in e.g., atrial fibrillation, or decreased clearing, possibly related to endothelial cell dysfunction, disturb this balance. This could lead to continuing loss of capillaries, micro-infarcts, and cognitive decline.
Sign in to start a discussion.
More Papers Like This
Microplastics in the bloodstream can induce cerebral thrombosis by causing cell obstruction and lead to neurobehavioral abnormalities
Researchers discovered that microplastics in the bloodstream can cause blood clots in the brain by getting swallowed by immune cells that then block tiny blood vessels. These blockages reduced blood flow and caused neurological problems in mice. This reveals a new way microplastics may harm the brain, not by crossing into brain tissue directly, but by disrupting blood circulation.
The impact of microplastics on neurodegenerative diseases and underlying molecular mechanisms: A narrative review
This review explores how microplastics that accumulate in the environment can reach the brain through inhalation or by crossing the blood-brain barrier. Researchers examined evidence suggesting that microplastics may contribute to the onset or acceleration of neurodegenerative conditions by triggering harmful responses in brain cells. The study calls for stronger environmental policies, better detection methods, and further research into potential therapeutic interventions.
Mechanisms of micro- and nanoplastics on blood-brain barrier crossing and neurotoxicity: Current evidence and future perspectives
This review examines evidence that micro- and nanoplastics can cross the blood-brain barrier, the protective shield around the brain, through multiple pathways including disrupting the barrier's tight junctions and being transported inside cells. Once in the brain, these particles may cause damage through oxidative stress, inflammation, mitochondrial dysfunction, and disrupted iron metabolism, with effects worsened when plastics carry other pollutants like heavy metals.
Crossing barriers – tracking micro- and nanoplastic pathways into the human brain
Researchers tracked potential pathways by which micro- and nanoplastics may enter the human brain, examining both in vitro cell models and post-mortem brain tissue. They found that human monocytes rapidly internalized polystyrene particles into endocytic vesicles and mitochondria, and detected plastic particles in brain tissue samples, providing evidence that nanoplastics may be capable of crossing brain barriers.
Microplastics and Their Effect on Neuroglia: A Narrative Review
This narrative review examines how microplastics — entering the body through inhalation, ingestion, and skin contact — may accumulate in neuroglial cells of the brain, raising concern about their role in neuroinflammation and neurodegenerative disease progression.